AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2578-8868/320
1Department of Neurosurgery, Instituto Hospital de Base do Distrito Federal, SMHS, Área Especial, quadra 101, 70330-150, Brasília, DF, Brazil.
2Hospital Universitário de Brasília, Setor de Grandes Áreas Norte, 605, Asa Norte, 70840-901, DF, Brazil.
*Corresponding Author: Vinicius Moreira Lima, Department of Neurosurgery, Instituto Hospital de Base do Distrito Federal, SMHS, Área Especial, quadra 101, 70330-150, Brasília, DF, Brazil.
Citation: Vinicius M. Lima, Clara D. Pereira, Plinio R. Maximo, Marcelle Rehem, Noel Peixoto, et al, (2024), Dural venous sinus angioplasty and stenting for treatment of idiopathic intracranial hypertension: a single-center experience with 20 consecutive cases, J. Neuroscience and Neurological Surgery, 14(5); DOI:10.31579/2578-8868/320
Copyright: © 2024, Vinicius Moreira Lima. This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Received: 10 May 2024 | Accepted: 27 May 2024 | Published: 14 June 2024
Keywords: idiopathic intracranial hypertension; dural sinus stenosis; angioplasty; stent
Background: Dural venous sinus stenosis has been shown to be a potential cause or aggravating factor of idiopathic intracranial hypertension (IIH). Endovascular therapy for angioplasty of venous sinus stenosis is emerging as a potential alternative to treat IIH.
Objective: This article aims to present the results of a cases series representing the experience of a single center in treating this disease.
Materials and Methods: We retrospectively reviewed the angiographic and manometric data of patients undergoing angioplasty and stenting for the treatment of IIH with venous sinus stenosis on magnetic resonance angiography. All patients had failed conventional medical treatment. Data on demographic features, clinical and radiologic presentation, and outcomes were collected retrospectively.
Results: 20 female patients, with persistent headache and papilledema, underwent venous sinus angioplasty and stenting. Mean age was 35.9 (SD, 10) years. Eighteen patients (90%) had clinical improvement after the procedure. Of these, all showed resolution (17 patients, 94%) or partial improvement (1 patient, 6%) of papilledema within 6 months. Two patients had persistent moderate-to-severe headache (intensity > 6 on a 10-point pain scale), with continued papilledema despite stable visual acuity on visual field testing. The mean pre-procedure lumbar puncture opening pressure was 30.1 (SD, 4) mm Hg, decreasing to 16.2 (SD, 4) mm Hg after the procedure. Only 4 patients experienced complications directly or indirectly related to the procedure, with no impact on outcome.
Conclusion: Angioplasty and stenting of the stenotic segment may effectively and safely treat IIH associated with focal venous sinus stenosis, with a high technical success rate and an acceptable complication rate.
IIH: idiopathic intracranial hypertension CSF: cerebrospinal fluid
ICP: intracranial pressure
VAS: visual analog scale
SD: standard deviation
Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a potentially debilitating disease with an average prevalence of 1 case per 100,000 population, preferentially affecting young women (aged 20 to 44 years).[1-3] The disease is characterized by decreased visual acuity, progressive headache, and pulsatile tinnitus associated with elevated cerebrospinal fluid (CSF) opening pressures on lumbar puncture.[1,2] Visual disturbance results from the transmission of intracranial pressure (ICP) to the optic nerve sheath, leading to bilateral papilledema, present in up to 95% of cases.[2,3] If left untreated, IIH can lead to optic nerve atrophy and permanent visual loss.[2-4]
Diagnosis is based on the criteria developed by Walter Dandy in 1937, modified over time as the understanding of the disease has advanced.[5,6] The most widely accepted criteria are (1) signs and symptoms referable only to elevated ICP, (2) CSF opening pressure > 25 cm H2O, (3) normal CSF composition, and (4) no evidence of mass lesion or other structural cause using modern imaging techniques.[6]
The cause of increased ICP remains controversial, and this doubt is responsible for different philosophies to approach the disease. However, intracranial venous hypertension leading to decreased CSF reabsorption has been implicated as a potential common pathway of IIH.[8,11] Recent studies have shown a direct relationship between the presence of focal stenosis in the dural sinuses, often in the sigmoid, transverse, or superior sagittal sinuses, and the presence of IIH. Focal stenosis was demonstrated in 30%-93% of patients with IIH vs 6.8% of the control population.[10] In a positive feedback loop, regardless of the initial cause of focal stenosis, venous hypertension proximal to the stenotic area leads to increased ICP causing continued extrinsic stenosis or worsening of pre-existing stenosis.[12]
Traditional treatment of IIH consists initially of the use of carbonic anhydrase inhibitors, reducing CSF production, and serial lumbar punctures for relief .[15, 21]. In case of treatment failure, CSF diversion procedures, especially lumboperitoneal shunt placement or optic nerve sheath fenestration, may be indicated.[14,15] Other measures such as weight loss, in some cases even requiring gastric bypass, can be effective in reducing ICP and improving visual symptoms.[14]
The success rate in controlling the disease reaches up to 80% of cases immediately after these procedures. However, recurrence of symptoms at 1 year can reach 50% for ventriculoperitoneal shunts and 40% for optic nerve sheath fenestration, [16] especially in patients with poor adherence to medical treatment.
With advances in neuroimaging, showing that most patients with IIH may have structural abnormalities of the venous sinuses, and improvements in endovascular techniques, adequate diagnosis of focal stenosis followed by venous sinus angioplasty and stenting has emerged as a potentially effective treatment strategy for IIH, although concrete data regarding its long-term durability and effectiveness are still lacking.[10,11,18, 19] In this paper, we present a series of 20 consecutive cases of patients with IIH with venous sinus stenosis treated with angioplasty and stenting in a single center.
We retrospectively reviewed 20 consecutive cases of female patients with confirmed IIH, receiving medical treatment in the neurology department, who underwent endovascular treatment with dural venous sinus angioplasty and stenting. Data on demographic features, clinical presentation, peri-procedural complications, and clinical-neurologic monitoring were collected. Regarding neurologic findings, the following variables were evaluated: headache type and intensity (visual analog scale [VAS]), tinnitus, presence or absence of papilledema, visual deficits documented by an ophthalmologist, and lumbar puncture opening pressure.
All patients received standard medical treatment with a carbonic anhydrase inhibitor and serial lumbar punctures for at least 3 months (with intervals of 2 to 4 weeks based on clinical progress), in addition to encouragement of behavioral changes (weight loss, physical activity). All patients had intrinsic or extrinsic stenosis in at least one dural venous sinus seen on magnetic resonance angiography evaluated by a neuroradiologist with no involvement in the intervention. During angiographic examination, in addition to confirming the stenotic lesion, pre- and post-stenosis manometry was performed to assess the real indication for stenting as previously defined (gradient > 8 mm Hg).
Data collected during the procedures included stenosis location and side, balloon used and stent placed, peri-procedural complications, procedure-related angiographic changes, stenosis severity, and pressure gradient in the stenotic area.
After a literature search and review in the main available sources, a comparison was made with the data obtained in this series.
Procedure
All procedures were performed with the patients under general anesthesia. All patients were pretreated with dual antiplatelet therapy starting 5 days before the procedure: 9 patients with aspirin 100 mg daily + clopidogrel 75 mg daily; and 11 patients with aspirin 100 mg daily + ticagrelor 90 mg every 12 hours.
Arterial access was obtained via the femoral artery with a 5F introducer sheath to perform cerebral digital subtraction angiography and to confirm the stenotic lesion and side, in addition to venous roadmap imaging. Venous access was obtained via the femoral vein in 80% of cases (16 patients) with an 8F introducer sheath or directly with a long sheath (Neuromax 088 or BMX 096). In the remaining patients, access was obtained via direct puncture of the jugular vein according to the side of the target stenotic region. All punctures were ultrasound guided to reduce access-related complications. After venous access, patients received 5000 IU of intravenous heparin.
Using a navigation system (select catheter and hydrophilic guidewire within a long sheath), the long sheath was placed at the level of the jugular bulb ipsilateral to the stenotic lesion to facilitate navigating the microcatheter distal to the stenosis. A 0.027-inch microcatheter was placed within the sheath and navigated over a 0.014-inch guidewire into the transverse-sigmoid sinus, and upstream and downstream pressure measurements were obtained from the stenosis. The stent would only be deployed if the pre- and post-stenotic pressure difference (gradient) was above 8 mm Hg, which was confirmed in all cases reported in this series. After pressure measurements, the microcatheter was removed and the 0.014-inch guidewire was advanced as far distally and safely as possible from the stenosis (superior sagittal sinus or contralateral jugular bulb), and then the stent was deployed across the stenosis. In cases of increased vessel tortuosity and navigation difficulties, an intermediate catheter (Benchmark 071) was used to assist with navigation and stent placement. Different stents were used to perform angioplasty, and the choice depended on patient-related factors (stenosis location and severity, vessel tortuosity, and difficulty in accessing and positioning components) as well as on the availability of stents. Details of the stents placed are provided below. In case of residual stenosis, compliant balloon post-dilation was performed.
Dual antiplatelet therapy was continued for 6 months after the procedure for all patients, and at least one follow-up computed tomography angiography or digital subtraction angiography was performed within 6 months.
Case 1: Young patient diagnosed with medically refractory IIH with headache and papilledema, with angiographic diagnosis of dural venous sinus stenosis at the right transverse-sigmoid sinus junction and venous manometry showing a gradient of 12 mm Hg (Figue 1).
Figure 1. Pre- and post-procedure images of venous sinus angioplasty with placement of 2 telescoping carotid stents (CASPER) and balloon. (A) Panoramic angiogram in the venous phase, anteroposterior (AP) view. (B) Primary balloon angioplasty at the site of focal stenosis before inserting the guiding catheter for stent placement. C: Final result after stent implantation, AP view.
Case 2: Young patient diagnosed with IIH with progressive visual loss, with angiographic diagnosis of dural venous sinus stenosis at the right transverse-sigmoid sinus junction and venous manometry showing a gradient of 10 mm Hg (Figure 2).
Figure 2. Pre- and post-procedure images of venous sinus angioplasty with placement of 1 carotid stent (PRECISE). Post-angioplasty manometry with a gradient of 0 mm Hg. (A) Venous phase angiogram, anteroposterior (AP) view, showing stenosis of the right transverse-sigmoid segment. (B) Navigation of the support system distal to the site of stenosis for subsequent stent deployment. (C) Final result after stent implantation, AP view.
From November 2015 to April 2023, 20 female patients diagnosed with IIH and stenosis in at least one dural sinus were treated with angioplasty and stenting at our institution. Table 1 shows the demographic and clinical characteristics of the study sample (Table 1). All patients were women, with a mean age of 35.9 (SD, 10) years. All patients had daily holocranial headache refractory to analgesics, with a mean intensity of 8.1 (SD, 1.4) on a 10-point VAS, papilledema, and some degree of decreased visual acuity. Five patients had associated pulsatile tinnitus. The mean pre-procedure lumbar puncture opening pressure was 30.1 (SD, 4) mm Hg.
| Mean age | 35.9 (±10) years | |
| Symptoms and clinical findings | Pre-angioplasty | Post-angioplasty (6-month follow-up) |
Headache frequency (headaches with pain intensity of VAS >3) | 20/20 | 6/20 |
| Headache intensity (mean) | 8.1 (± 1.4) | 2.65 (± 2) |
| Tinnitus | 5 | 1 |
| Visual acuity | 18/20 | 5/20 |
| Papilledema | 20/20 | 3/20 |
| Opening pressure | 30.1 (± 4) mm Hg | 16.2 (± 4) mm Hg |
| Pressure gradient | 15 (± 4) mm Hg | 2.8 (± 1.7) mm Hg |
Legend: VAS, visual analog scale.
Table 1. Demographic and clinical data of the study sample (n = 20 female patients)
At 6-month follow-up, headache improved substantially in 90% (18/20) of patients, with 12 patients showing near-resolution of headache in frequency and intensity (VAS < 3), with the mean intensity decreasing to 2.65 (SD, 2) in 10 of all 20 patients. Tinnitus was eliminated in 4 of the 5 patients reporting tinnitus prior to the intervention. CSF opening pressure on follow-up lumbar puncture decreased to 16.2 (SD, 4.3) mm Hg, and papilledema resolved in 85% (17/20) of patients. No patient had worsening of visual acuity on ophthalmologic examination, with 75% reporting improvement and 25% stabilization of vision compared with pre-procedure visual acuity.
Headache, papilledema, and lumbar puncture opening pressure did not improve in 1 patient, and her treatment was considered to have failed.
The mean pre-procedure trans-stenosis pressure gradient decreased from 15 (SD, 4) mm Hg to 2.8 (SD, 1.7) mm Hg in patients with successful angioplasty. Even in the patient with a failed treatment at the end of follow-up, a post-angioplasty gradient < 8 mm Hg was obtained (cutoff to indicate treatment).
Regarding stenosis location, 9 occurred in the transverse sinus (3 right and 6 left), 3 in the sigmoid sinus (2 right and 1 left), and 7 in the transverse-sigmoid junction (4 right and 3 left). In 1 case, stents were placed at 2 different sites of stenosis (1 in the transverse sinus and 1 in the jugular bulb), both on the same side (on the left). Regarding stents, 19 were self-expanding stents (5 WallStent, 7 Casper, 5 Precise, and 2 CGuard) and 1 was a balloon-mounted stent (Table 2).
There were no intraoperative complications, but 1 patient developed a large inguinal hematoma in the first 24 hours post-procedure, without clinical or laboratory repercussions, which was managed conservatively.
One patient developed significant gastrointestinal bleeding after 3 months of antiplatelet therapy, and clopidogrel was discontinued at the time, without neurologic repercussions. The patient had a patent stent on the 6-month follow-up angiography.
On the 6-month follow-up angiography, 1 patient showed a new stenosis proximal to the stented segment, without clinical repercussions, which was managed conservatively. No instances of in-stent thrombosis or significant neointimal hyperplasia were observed. The patient whose treatment was considered to have failed showed no abnormal findings on follow-up angiography and was referred for evaluation for lumboperitoneal shunt placement.
| Stenosis location | Side | Stent placed | Complications (overall) | Follow-up imaging (6 months) |
| Transverse | L | WallStent | Gastrointestinal bleeding | Patent stent |
| Transverse | L | WallStent | — | Patent stent |
Sigmoid | L | WallStent | — | Patent stent (new stenosis proximal to the stent) |
| Sigmoid | R | Casper | — | Patent stent |
| Transverse | R | Casper | Hematoma at the puncture site | Patent stent |
| Transverse | L | WallStent | — | Patent stent |
| Transverse | L | Casper | — | Patent stent |
| Sigmoid | R | WallStent | — | Patent stent |
| Transverse | L | Casper | Failed treatment | Patent stent |
| Transverse and sigmoid | R | Precise | — | Patent stent |
| Transverse | R | Casper | — | Patent stent |
| Transverse | R | Precise | — | Patent stent |
| Transverse | L | Precise | — | Patent stent |
Transverse and jugular bulb | L | Casper | Vocal cord paralysis secondary to intubation (resolved with speech therapy) | Patent stent (on CT angiography) |
| Transverse and sigmoid | R | Precise | — | Patent stent |
| Transverse and sigmoid | L | Balloon-mounted stent (Medtronic) | — | Patent stent (on CT angiography) |
| Transverse and sigmoid | R | Casper | — | Patent stent |
| Transverse and sigmoid | L | Precise | — | Patent stent (on CT angiography) |
| Transverse and sigmoid | L | CGuard | — | Patent stent (on CT angiography) |
Transverse and sigmoid | R | CGuard | Small cortical SAH immediately after, without clinical repercussions | Patent stent (on CT angiography) |
Legend: L: left; R: right; CT: computed tomography, SAH: subarachnoid hemorrhage.
Table 2. Angioplasty data
IIH remains a poorly understood disease with an important predilection for overweight young women. Every year, 0.9 to 1.07 per 100.000 persons develop IIH.[1,10] Generally, these patients present with pulsatile tinnitus, papilledema, and progressive visual loss.[1,2] Recent studies have demonstrated an association between focal stenosis in the dural venous sinus outflow and IIH in up to 93% of cases.[1,10] Apparently, these stenoses can act as a cause or aggravating factor of the disease to such an extent that angioplasty of the stenotic lesions has proven to be a new treatment strategy.[18]
Unfortunately, failure to diagnose venous stenosis is not rare, with the stenotic lesion being interpreted as a normal anatomic variant or the presence of arachnoid granulations. Higgins et al evaluated 20 patients with IIH whose brain magnetic resonance angiography scans were initially reported as normal and later assessed specifically for stenoses. Of the 20 patients, 13 were reclassified as having some degree of stenosis.[16]
In the present study, most patients (90%) showed some clinical improvement, whether subjective (headache and tinnitus) or objective (papilledema and CSF opening pressure). Although only 60% (12/20) of patients showed resolution or near-resolution of all symptoms, there was no progression of visual loss in the study sample (visual acuity stabilized or improved in 100% at 6-month follow-up), highlighting the positive impact of the treatment used.
Our data are consistent with other recently published series. Regarding headache, most case series report improvement but not complete resolution for the majority of patients.[1,2,10,16,17] One case series reported that 10 of 12 patients had persistent headache in some form, although papilledema resolved in all of them.[1] A case series from the Barrow Neurological Institute reported only improvement of headache, without complete resolution of symptoms.[10] In our series, one patient showed no clinical improvement, in addition to maintaining elevated CSF opening pressure on follow-up lumbar puncture despite adequate stent implantation and a pressure gradient consistent with the indication for angioplasty, being the only patient in the sample considered to have a failed treatment. This patient showed significant weight gain (12 kg in 6 months), and this factor influenced her response to treatment, as impaired venous return at the thoracic level and the consequent reduction in dural venous sinus outflow can explain this condition. A second patient had only partial improvement of headache and visual acuity, with a stable visual field (unchanged papilledema on ophthalmologic examination) and normal opening pressure at 6-month follow-up. Optimized medical therapy was maintained and close monitoring of symptoms and papilledema was proposed.
An important finding was the low complication rate both during and after the procedure. Only 4 patients experienced adverse events: 2 cases of procedural complications (1 hematoma at the puncture site and 1 cortical subarachnoid hemorrhage); 1 case related to antiplatelet therapy (gastrointestinal bleeding); and 1 case related to orotracheal intubation (vocal cord paralysis). None of the complications resulted in worsening of severity or outcome of the patients within 6 months. Although the systemic bleeding event occurred in the group of patients using clopidogrel, due to our small sample size, we cannot conclude about the efficacy/safety between the two different antiplatelet regimens (aspirin + clopidogrel and aspirin + ticagrelor).
A limitation of this study is that the data originate from a retrospective series with a limited number of cases. Nevertheless, the data are in line with those published in the literature and the results are promising. We can infer that dural sinus angioplasty is a safe procedure and that adverse events should become even rarer with the increasing number of cases with an indication for treatment, growing expertise of the teams, and improvements in the techniques and materials used.
In patients diagnosed with IIH associated with focal venous sinus stenosis and venous manometry indicating a pressure gradient > 8 mm Hg, angioplasty and stenting of the stenotic segment may represent an effective and safe treatment strategy with a high technical success rate and an acceptable complication rate. The analysis of data from the present study reflects the current clinical evidence, showing that venous sinus stenting is beneficial for these patients. However, larger prospective studies comparing the different treatment approaches, as well as those that show long-term clinical and radiological follow-up are needed to help determine the optimal approach in these patients.
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
None.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
